Change of Adviser

RNS Number : 0929P

Allergy Therapeutics PLC

27 September 2013

 



27 September 2013

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Change of Adviser

Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, is pleased to announce the appointment, with immediate effect, of Peel Hunt LLP as its Nominated Adviser and Broker.

-Ends-

For further information

Allergy Therapeutics	[phone]
Manuel Llobet, Chief Executive Officer Ian Postlethwaite Finance Director
Peel Hunt LLP	[phone]
James Steel/Dr Vijay Barathan

 

END

 

 

APPFMGZLNNZGFZG